Showing results (251-260 of 382) with videos related to
Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2018
Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall SurvivalEmmanuel S Antonarakis, Eric J Small, Daniel P Petrylak, et al.The Journal of Urology|March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the BladderGuarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention TrialIbrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.Urologic Oncology|June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectivesEzra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.BJU International|October 12, 2021
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registryHamed Ahmadi, Seyedeh Sanam Ladi-Seyedian, Badrinath Konety, et al.Pageof 39